Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Random, Double-blind, Parallel, Placebo-controlled, Multi-center Study of Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism

NCT03090113 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT03090113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03090113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Random, Double-blind, Parallel, Placebo-controlled, Multi-center Study of Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism
Lead sponsor
Beijing Tiantan Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 12, 2017
Completion date
June 21, 2019
Enrollment
2,416 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

embolic stroke